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Abstract
Background: People with prediabetes are at greater risk for heart attack, stroke, kidney disease, vision problems,
nerve damage and high blood pressure, compared to those without the disease. Prediabetes is a complex disorder
involving both genetic and environmental factors in its pathogenesis. This cross-sectional study aimed to investigate
the independent risk factors for prediabetes, considering the contribution of genetic factors (TCF7L2-rs7903146,
IRS1-rs1801278, INSR-rs3745551, CDKN2A-rs10811661, and FTO-rs9939609), socio-economic status, and lifestyle factors.
Results: Among the candidate genes studied, the CDKN2A-rs10811661 polymorphism was found to be the most
significant factor associated with prediabetes in the model unadjusted and adjusted for age, sex, obesity-related
traits, systolic blood pressure, dyslipidemia, socio-economic status, and lifestyle factors. In the final model, the
CDKN2A-rs10811661 polymorphism (OR per T allele = 1.22, 95 % CI = 1.04–1.44, P = 0.017), systolic blood pressure
(OR per 10 mmHg = 1.14, 95 % CI = 1.08–1.20, P < 0.0001), waist-hip ratio (OR = 1.25, 95 % CI = 1.10–1.42, P < 0.0001),
dyslipidemia (OR = 1.57, 95 % CI = 1.15–2.14, P = 0.004), and residence (OR = 1.93, 95 % CI = 2.82–4.14, P < 0.0001) were
the most significant independent predictors of prediabetes, in which the power of the adjusted prediction model
was 0.646.
Conclusions: The study suggested that the CDKN2A-rs10811661 polymorphism, waist-hip ratio, systolic blood pressure,
and dyslipidemia were significantly associated with the increased risk of prediabetes in a Vietnamese population. The
studied genetic variant had a small effect on prediabetes.
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Background
Prediabetes is the condition where blood sugar levels are
higher than normal, but not yet high enough to be clas-
sified as diabetes [1]. The importance of prediabetes has
been underscored by the facts that (i) up to 70 % of
people with prediabetes may develop type 2 diabetes
(T2D) during their lifetimes [2]; (ii) the average time it
takes a person with prediabetes to develop T2D is 3
years [3]; and (iii) people with prediabetes are at greater
risk for heart attack, stroke, kidney disease, vision
problems, nerve damage and high blood pressure, com-
pared to people without the disease [4, 5]. However,
prediabetes is reversible and its related metabolic disor-
ders can be improved with proper treatment [6]. Thus, it
is crucial to identify risk factors for prediabetes to pre-
vent a person from developing this disorder.
Predisposition to prediabetes could be determined by
many different combinations of genetic variants and
environmental factors. Environmental factors that can
increase risk for prediabetes and T2D include lifestyle
habits (a sedentary lifestyle and poor nutrition, smoking
and excessive alcohol consumption), overweight or obese,
poor sleep, age, high blood pressure, and abnormal lipid
levels [7, 8]. Genetic factors contribute to development of
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prediabetes and T2D. Defects in genes that encode
proteins affect pathways involved in insulin control and
glucose homeostasis (the balance of insulin and the
hormone glucagon to maintain blood glucose), hence can
raise the risk for diabetes. Such genes including INSR,
IRS1, CDKN2A, TCF7L2, and FTO are also identified in
genome wide association (GWA) studies [9, 10]. The con-
tributions of these genetic variants on T2D vary among
different ethnic populations because of the differences in
environmental factors, risk–factor profiles, and genetic
background [8, 11]. It is unclear whether these variants
have the same effect in Vietnamese population, which has
different socio–economic and genetic background. More-
over, the importance of each risk factor for prediabetes
which varies within a specific population needs to be
clarified. To date, there has been a limited data on risk
factors for prediabetes in Vietnamese population.
Therefore, the study was designed to investigate both
genetic (TCF7L2-rs7903146, IRS1-rs1801278, INSR-rs3745551,
CDKN2A-rs10811661, and FTO-rs9939609) and environmen-
tal factors for prediabetes in a Vietnamese population.
The most significant factors associated with prediabetes
were also reported.
Methods
Subjects and data collection
The study included 2,610 subjects (411 prediabetic cases
and 2,199 normoglycemic controls). They were recruited
from a cross-sectional and population-based study to be
representatives of prediabetic subjects and normo-
glycemic controls in the general population of the Red
River Delta, Vietnam. Of the total 2,610 participants,
2,608 (99.9 %) belonged to Kinh ethnic group. The Eth-
ics Committee of the National Institute of Hygiene and
Epidemiology, Vietnam approved the study. All partici-
pants provided written informed consent before entering
the study. The details of the survey to collect data were re-
ported previously [12]. In summary, data were collected
on social-economic status (current age, gender, ethnicity,
educational level, occupation, marital status, income
level), lifestyle patterns (residence, alcohol consumption,
smoking history, time spent for night’s sleep, siesta, and
watching television), family history of diabetes, medical and
reproductive history. Anthropometric parameters measured
included weight, height, waist circumference (WC), hip cir-
cumference (HC), percent body fat, systolic blood pressure
(SBP), and diastolic blood pressure (DBP). Blood samples
were collected and centrifuged immediately in the morning
after a participant had fasted for at least 8 h prior to the
clinic visit. Plasma glucose was measured by glucose oxi-
dase method (GOD–PAP). Lipid profile including total
cholesterol (TC), triglycerides (TG), high-density lipopro-
tein cholesterol (HDL-C), and low-density lipoprotein chol-
esterol (LDL-C) were measured by enzymatic methods.
Glucose and lipid profile were analyzed using a semi–
autoanalyzer (Screen Master Lab; Hospitex Diagnostics
LIHD112, Italy) with commercial kit (Chema. Diagnostica,
Italy). Dyslipidemia [13] is defined as HDL-C < 40 mg/dL
for men and < 50 mg/dL for women, and TC, LDL-C and
TG levels ≥ 200, ≥ 130 and ≥ 130 mg/dL, respectively.
The glycaemic status of subjects was determined using
fasting plasma glucose level (FPG) and oral glucose toler-
ance test (OGTT) with 75 g glucose [14]. Participants were
classified as having diabetes if they had FPG ≥ 7.0 mmol/l
or 2-h plasma glucose ≥ 11.1 mmol/l or previous diagnosis
of diabetes and current use of drug for its treatment.
Normal glucose tolerance (NGT) was classified when
FPG < 5.6 mmol/l and 2-h plasma glucose < 7.8 mmol/l.
Isolated impaired fasting glucose (IFG) was identified if
FPG was between 5.6 and 6.9 mmol/l, and 2-h plasma glu-
cose was less than 7.8 mmol/l. Isolated impaired glucose
tolerance (IGT) was classified if FPG was less than
5.6 mmol/l and 2-h plasma glucose was between 7.8 and
11.0 mmol/l. Combined IFG and IGT (IFG − IGT) were
determined if FPG was between 5.6 and 6.9 mmol/l, and
2-h plasma glucose was between 7.8 and 11.0 mmol/l.
Prediabetic status included IFG and/or IGT.
Genotyping
Peripheral blood samples were obtained from each
participant and genomic DNA was extracted from pe-
ripheral blood leukocytes, using Wizard® Genomic DNA
Purification Kit (Promega Corporation, USA). Primers,
protocols of polymerase chain reaction, and restriction en-
zymes for genotyping the polymorphisms are presented in
Additional file 1. Our typing strategy was to use the
allele–specific primer (ASP) typing method [15], then
10 % of all samples were typed using restriction fragment
length polymorphism (RFLP) analysis to validate observed
results. There were more than 98 % agreement of the
result between ASP typing method and RFLP analysis in
the samples checked. In addition, samples were selected
randomly and re-genotyped using the original platform.
The results showed that the concordance rate was
96–99 % with respect to the 30 % of samples genotyped
twice for quality control.
Statistical analysis
Genotypes were coded as 0, 1, and 2, depending on the
number of copies of risk alleles. Genotype frequencies
were compared and tested for Hardy–Weinberg equilib-
rium (HWE) by Fisher’s exact test. Five genetic models
were tested (dominant, co-dominant, over-dominant,
recessive, and additive model). Akaike’s Information
Criterion and Bayesian Information Criterion were
applied to estimate the best-fit model for each SNP. The
procedure was performed in SNPstat software [16].
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Quantitative variables were checked for normal distri-
bution and compared using Mann–Whitney U test.
Binary logistic regression analysis was used to test
several models for the associations of prediabetes with
the risk alleles and other variables, taken into account
the covariates (age, sex, socio-economic status, lifestyle
factors, obesity–related traits (BMI, WC, HC, WHR, and
percent body fat), systolic blood pressure, and lipid pro-
file). The variables included in the analyses were checked
for multicollinearity to ensure the stability of the para-
meter estimates. Here, data are presented as odds ratios
with 95 % confidence intervals (CI). In order to assess
the model performance, a receiver operating characte-
ristic (ROC) curve was built to plot probabilities resulted
from the multivariate logistic regression analysis, and
the area under ROC curve (AUC) was used to measure
the power to predict individuals with prediabetes. The
level of significance was set to 0.05 for all analyses. The
above statistical procedures were performed using SPSS
version 16.0 (SPSS, Chicago, USA). The Bayesian model
averaging was used to cross-validate the final model
using Bayesian Model Averaging Software with the R
Statistical Environment version 3.1.3 [17].
Results
Characteristics of the study subjects
Of the 2,610 participants recruited into the study, 65.4 %
were women, 72.6 % were farmers, and 72.2 % had elem-
entary or intermediate levels of education. The charac-
teristics of subjects in prediabetic cases and controls are
shown in Table 1. There were significant differences be-
tween prediabetic and control groups in age, BMI, waist
circumference, WHR, systolic blood pressure, diastolic
blood pressure, total cholesterol, HDL −C, and trigly-
ceride. Significant differences between cases and controls
were not found in gender, height, weight, body fat per-
cent, hip circumference, nutrition status, and LDL −C.
Associated factors for prediabetes
Socioeconomic status (age, marital status), lifestyle patterns
(residence, alcohol consumption), anthropometric traits
(BMI, WC, WHR, and SBP), and lipid profile (TC, TG, and
LDL-C) were significantly associated with prediabetes in
univariate logistic regression (Additional file 2). The ana-
lysis of the best-fit model for individual SNPs in candidate
genes with prediabetes among genetic models of inhe-
ritance (additive, codominant, dominant, overdominant,
Table 1 Characteristics of subjects in prediabetic cases and controls
Characteristics Prediabetic cases Controls Total P − value
(N = 411) (N = 2199) (N = 2610)
Male, n (%) 152 (37 %) 752 (34.2 %) 904 (34.6 %) 0.276
Age (year) 53 (47–57.8) 51 (46–56) 51 (46–56) <0.0001
Weight (kg) 51.8 (46–57.9) 51(46.3 − 56.5) 51 (46.2 − 56.6) 0.117
Height (cm) 155.5 (150.5 − 160) 155 (150.7 − 160) 155 (150.6 − 160 0.731
Body mass index (kg/m2) 21.5 (19.6 − 23.4) 21.1 (19.3 − 22.9) 21.2 (19.4 − 23) 0.012
Body fat (%) 28.2 (23.7 − 31.9) 27.5 (22.9 − 31.5) 27.6 (23.2 − 31.6) 0.119
Waist circumference (cm) 75 (69–82) 73.5 (68.5 − 79) 74 (68.5 − 79.5) 0.002
Hip circumference (cm) 88 (84–92) 88 (84–91.3) 88 (84–91.5) 0.628
Waist − hip ratio 0.85 (81–0.90) 0.84(0.80 − 0.88) 0.84 (0.80 − 0.88) <0.0001
Nutrition status
Normal 237 (57.8) 1342 (61.4) 1579 (60.8) 0.129
Overweight 77 (18.8) 344 (15.7) 421 (16.2)
Obesity 44 (10.7) 183 (8.4) 227 (8.7)
Underweight 52 (12.7) 316 (14.5) 368 (14.2)
Systolic blood pressure (mmHg) 120 (110–137.5) 110.3 (100–127.5) 115 (110–130) <0.0001
Diastolic blood pressure (mmHg) 80 (70–85) 70 (65–80) 70 (65–80) <0.0001
Total cholesterol (mmol l−1) 4.60 (4.09 − 5.00) 4.20 (3.85 − 4.87) 4.30 (3.90 − 4.90) <0.0001
HDL − C (mmol l−1) 1.19 (0.97 − 1.60) 1.23 (0.99 − 1.60) 1.22 (0.98 − 1.60) <0.0001
LDL − C (mmol l−1) 3.10 (2.64 − 3.70) 2.79 (2.31 − 3.31) 2.83 (2.34 − 3.40) 0.103
Triglyceride (mmol l−1) 1.80 (1.12 − 2.55) 1.34 (1.00 − 2.02) 1.41 (1.01 − 2.10) <0.0001
HDL − C, high-density lipoprotein − cholesterol; LDL − C, low-density lipoprotein − cholesterol. Quantitative data are median (interquartile range). Qualitative data
are number (%). P-value by Mann–Whitney U test or chi-square test
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and recessive) is shown in Additional file 3. The lowest
values of both Akaike’s Information Criterion and Bayesian
Information Criterion were only found in the additive
model, indicating this best-fit model in all studied SNPs.
The association of prediabetes with residence, mari-
tal status, alcohol consumption, WHR, SBP, dysli-
pidemia, and CDKN2A-rs10811661 polymorphism was
observed in multivariate analysis (Table 2), considering
the contribution of genetic factors, anthropometric
measurements, lipid profile, socio-economic status and
lifestyle factors. The prediction model using the most
significant predictors of prediabetes is presented in
Table 3. In the final model, the CDKN2A-rs10811661
polymorphism (OR per T allele = 1.22, 95 % CI = 1.04–
1.44, P = 0.017), systolic blood pressure (OR per
10 mmHg= 1.14, 95 % CI = 1.08–1.20, P < 0.0001), waist–
hip ratio (OR = 1.25, 95 % CI = 1.10–1.42, P < 0.0001), dys-
lipidemia (OR = 1.57, 95 % CI = 1.15–2.14, P = 0.004), and
residence (OR = 1.93, 95 % CI = 2.82–4.14, P < 0.0001)
were the most significant independent predictors of pre-
diabetes. The independent variables in the final model
were also confirmed using the Bayesian model averaging
(Additional file 4). The area under ROC curve for the pre-
diction model of prediabetes on the predictors including
Table 2 Multivariate analysis of association for prediabetes
Variable OR (95 % CI) P-value Variable OR (95 % CI) P-value
Sex Residence
Female 1 Rural 1
Male 0.78 (0.45–1.33) 0.354 Urban 3.95 (2.50–6.23) <0.0001
Age (year) 1.02 (0.99–1.04) 0.075 Alcohol consumption
Marital status None 1
Married 1 < 1 drink/mo 1.14 (0.62–2.09) 0.686
Never 2.14 (1.01–4.55) 0.048 ≥ 1 drink/mo to < 1 drink/wk 2.02 (1.15–3.56) 0.015
Widowed 0.92 (0.53–1.60) 0.766 1 drink/wk to≤ 1 drink/d 1.49 (0.87–2.55) 0.147
Others 0.87 (0.29–2.57) 0.800 ≥ 2 drink/d 2.06 (1.16–3.68) 0.014
Education level Smoking
Elementary 1 None 1
Intermediate 0.97 (0.63–1.50) 0.904 Current smoker 0.75 (0.44–1.28) 0.293
Secondary 0.99 (0.56–1.76) 0.987 Ex–smoker 1.01 (0.57–1.77) 0.987
Post–secondary 0.89 (0.48–1.62) 0.691 Watching televison time/day
Heavy occupation ≤ 3 h 1
Yes 1 > 3 h 0.81 (0.44–1.51) 0.513
No 0.95 (0.64–1.41) 0.800 Sleeping time/day
Income level 6–7 h 1
< 25 percentiles 1 < 6 h 0.90 (0.62–1.31) 0.584
25– < 50 percentiles 1.25 (0.86–1.82) 0.246 ≥ 8 h 0.99 (0.72–1.39) 0.996
50–75 < percentiles 0.94 (0.63–1.40) 0.749 Sitting time/day
≥ 75 percentiles 0.99 (0.67–1.48) 0.984 ≤ 4 h 1
> 4 h 0.96 (0.73–1.28) 0.790
Systolic blood pressure (SD = 10 mmHg) 1.11 (1.04–1.19) 0.001 Siesta time/day (SD = 15 min) 1.08 (1.01–1.15) 0.020
Dyslipidemia Each of the following obesity-related measurements:
No 1 Waist-hip ratio (SD = 0.07) 1.21 (1.03–1.41) 0.019
Yes 1.48 (1.04–2.09) 0.027 Waist circumference (SD = 7 cm) 1.12 (0.98–1.27) 0.086
CDKL2A-rs10811661 per copy of T allele 1.23 (1.03–1.46) 0.022 Hip circumference (SD = 7 cm) 1.01 (0.85–1.21) 0.873
TCF7L2-rs7903146 per copy of T allele 1.13 (0.64–2.01) 0.676 Body mass index (SD = 0.25 kg/m2) 1.12 (0.99–1.28) 0.079
IRS1-rs1801278 per copy of G allele 1.01 (0.57–1.79) 0.967 Body fat (SD = %) 1.22 (0.90–1.66) 0.206
INSR-rs3745551 per copy of G allele 1.05 (0.86–1.27) 0.648
FTO-rs9939609 per copy of A allele 0.98 (0.79–1.22) 0.852
SD, standard deviation. One drink was defined as a 50–ml cup of rice wine at about 30 %
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residence, waist-hip ratio, and systolic blood pressure,
dyslipidemia and CDKN2A-rs10811661 polymorphism
was 0.646 (95 % CI: 0.614 − 0.677, P < 0.0001). Adding the
genetic marker to the clinical covariates improved the area
under ROC curve slightly from 0.637 to 0.646 (P < 0.019,
Wilcoxon Signed Ranks Test) (Fig. 1).
Discussion
Of the 5 candidate SNPs tested for association, we found
that the CDKN2A-rs10811661 polymorphism was sig-
nificantly associated with prediabetes in a Vietnamese
population, independent of obesity-related traits, consid-
ering the influence of the socio-economic status and life-
style factors. The association of the CDKN2A-rs10811661
polymorphism with T2D was initially reported in White
populations [18–20], and subsequently replicated in
Asian populations [21–23]. The CDKN2A-rs10811661
polymorphism was significantly associated with T2D in
Japaneses (OR = 1.25, 95 % CI = 1.08–1.45, P = 0.0024) [22],
and in Indians (OR = 1.37, 95 % CI = 1.18–1.59, P= 5.1E-05)
[24]. In Chinese populations, the CDKN2A-rs10811661
polymorphism was associated with increased risk in both
prediabetes (OR = 1.23, 95 % CI = 1.11–1.36) and T2D
(OR = 1.46, 95 % CI = 1.01–2.11) in a case–control study
and confirmed in a prospective study that the risk allele of
rs10811661 increased the risk of incident T2D by 94 %
[25]. Moreover, in GWA studies in Asians, the variant was
associated with T2D in East Asians (Han Chinese and
Japanese) (OR = 1.23, 95 % CI = 1.18–1.29, P = 1.43E-18)
[26], and a large multi-center GWA study replicated the
Table 3 The most significant independent predictors of prediabetes
Variable Unit Coefficient Odds ratio (95 % CI) P–value
Waist to hip ratio 0.07 0.224 1.25 (1.10 − 1.42) <0.0001
Systolic blood pressure 10 mmHg 0.124 1.13 (1.07 − 1.20) <0.0001
Dyslipidemia 0 = no, 1 = yes 0.453 1.57 (1.15 − 2.14) 0.004
Residence 0 = rural, 1 = urban 1.038 1.93 (2.82 − 4.14) <0.0001
CDKN2A-rs10811661 Number of T allele 0.201 1.22 (1.04 − 1.44) 0.017
Intercept −6.581 - <0.0001
P-value by multivariate logistic regression
Fig. 1 ROC curvers for the prediction models on the number of risk allele of CDKN2A-rs10811661, residence, waist-hip ratio, systolic blood pressure,
and dyslipidemia in model 2 and model 1 without genetic marker
Binh et al. BMC Genetics  (2015) 16:107 Page 5 of 8
association in both East Asians (OR = 1.25, 95 % CI =
1.17–1.32, P = 6.3E-13) and South Asians (OR = 1.20, 95 %
CI = 1.11–1.31, P = 1.4E-05) [27]. These studies showed
that the effect of the variant in CDKN2A gene seemed
slightly higher in T2D compared to prediabetes in the
present study (OR = 1.22, 95 % CI = 1.04–1.44, P = 0.017).
On the other hand, this polymorphism was not associated
with prediabetes in German people [28]. Given the multi-
factorial pattern of prediabetes, the contribution of the
CDKN2A-rs10811661 polymorphism varies among popu-
lations depending on the socio–economic status, lifestyle
factors, genetic background, and risk − factor profile of
each population [29].
There were many factors influencing the association
between the CDKN2A-rs10811661 polymorphism and
prediabetes, including bias selection of subjects, con-
founding factors such as socio–economic condition, and
lifestyle factors. The bias selection in the study was
controlled since the subjects were recruited from the
population − based screening survey with a sample size
representative of all prediabetic cases and normoglycemic
controls in the general population. Moreover, given the
multifactorial nature of prediabetes, the association in our
study was investigated in several analysis models, which
considered the various factors including sex, age, systolic
blood pressure, obesity − related traits (BMI, WC, WHR,
and body fat percentage), socio–economic patterns
(occupation, education level, residence, marital status,
income level), and lifestyle factors (smoking, alcohol con-
sumption, leisure time spent sitting, watching TV, and
siesta). Thereby, the statistically significant association be-
tween the CDKN2A-rs10811661 polymorphism and predi-
abetes was found to be independent of the traditional risk
factors.
Regarding the allele and genotype frequencies of the
CDKN2A-rs10811661 polymorphism, we found that the
risk T allele frequency was 57.6 %, and the frequencies of
CC, CT, and TT genotypes were 18.9, 46.9, and 34.2 %, re-
spectively in the total sample. The allele and genotype
frequencies in our sample were similar to those in Asian
populations (Han Chinese: 57 %, Japanese: 52.4 %) and
different from those in European (77.8–80.1 %) and
African (89–98.2 %) populations based on HapMap data [30].
Being obesity, which is associated with insulin re-
sistance and dysfunction of beta cell, is one of the most
important risk factors for the development of prediabe-
tes [31]. Among obesity-related traits, WHR was re-
cognized to be the most significantly associated with
prediabetes in our population. In the present study, the
association between the CDKN2A-rs10811661 poly-
morphism and prediabetes was consistently significant
when adding each of the obesity − related traits in the
analysis models including age, gender, systolic blood
pressure, socio-economic status and lifestyle factors,
indicating the direct effect of the CDKN2A-rs10811661
polymorphism on prediabetes, independently of the
obesity–related traits.
In terms of predictors of prediabetes, few genetic studies
have been reported although the importance of prediabetes
has been underscored. The present data showed an
increased prediabetes risk with an additive effect of the
alleles of CDKN2A-rs10811661 (OR per T allele = 1.22,
95 % CI = 1.04–1.44, P = 0.017). Our finding supports the
association of the CDKN2A-rs10811661 polymorphism
with prediabetes reported in previous case–control studies
in Asian populations [22, 23, 25, 28]. Moreover, the pre-
dictive effect of the CDKN2A-rs10811661 polymorphism
on the incident T2D was also confirmed in a 3.5 year
follow-up study [28]. These findings can be explained by
the evidences that a reduced insulin release was observed
for the CDKN2A-rs10811661 T-allele after both oral and
intravenous glucose challenges [20] and that the SNP was
significantly associated with early-phase insulin release
[32]. Among the independent risk factors for prediabetes,
WHR, dyslipidemia, and systolic blood pressure demon-
strated the strongest effects in our findings, which is in
agreement with previous studies [33–35]. Adding the gen-
etic marker to the clinical covariates in our study im-
proved slightly the area under the receiver operating
characteristic curve from 0.637 to 0.646 (P < 0.019), indi-
cating that the studied variant had a small effect on
prediabetes.
Indeed, some advantages could be highlighted in this
study. Since this is a large population-based study in the
Red River Delta region, Vietnam, the findings of the study
will be interpreted for general population of this region in
both genetic pattern and risk factor profile. The studied
population could be considered as a homogeneous sample
of the Kinh ethnic adults aged 40–64 years in a rural
province without other ethnic admixtures. Prediabetes in-
cluding IFG and/or IGT was determined using fasting
plasma glucose level and oral glucose tolerance test with
75 g glucose. This method has been widely accepted and
frequently referred as the “gold standard” for diagnosis of
prediabetes. However, several limitations should be noted
in this study. First, the limitation of the cross-sectional
study design does not allow for conclusions of the causal
relationships. Next, among many candidate SNPs have
been proposed to be associated with T2D and prediabetes,
the present study was only interested in 5 SNPs in genes
related to insulin pathway, and thereby the studied genetic
variant had a small effect on prediabetes despite statistical
significance. Lastly, the area under ROC curve of 0.646
shows the poor power of prediction of the model.
Conclusions
These data demonstrate that the CDKN2A-rs10811661
polymorphism, waist–hip ratio, systolic blood pressure,
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and dyslipidemia were significantly associated with the
increased risk of prediabetes in a Vietnamese population.
The association remains consistent after adjustment for
age, gender, socio-economic status, and lifestyle-related
factors. Because of the small contribution of the single
CDKN2A–rs10811661 polymorphism, it is necessary to
conduct a large-scale prospective study on prediabetes
and T2D in Vietnamese population.
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